Impact of long-term N-acetylcysteine use on cancer risk
It suppresses appetite, slows gastric emptying, and changes how your brain responds to food cues
A naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine) found in human plasma, studied for effects on wound healing, collagen synthesis, antioxidant activity, skin remodelling, and anti-inflammatory markers (investigational)
A support system: Access to a clinical team to answer your questions and guide you through the process
These could point to an underlying gut issue called small intestinal bacterial overgrowth (SIBO)
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products